PANXEON reads three signals to catch pancreatic cancer sooner

An AI-scored liquid biopsy from City of Hope caught stage 1 and 2 pancreatic cancer 87% of the time in…

By

Editor's Top Picks

One AI watchdog now covers every ward in Abu Dhabi

A year after launch, the emirate's health department says its AI patient safety platform now connects 100% of hospitals and…

By

Your one-stop resource for medical news and education.

Your one-stop resource for medical news and education.

Cureety absorbs Reimagine Care to watch cancer patients between visits

Cureety acquires Reimagine Care, pairing AI-driven triage with oncology clinical teams across 250 centers.

By

Heartvue’s cardiac MRI AI clears FDA with self-update built in

FDA clearance for Heartvue.Proton includes a PCCP that lets the cardiac MRI AI learn without refiling.

By

Ono taps Aitia’s causal AI twins to unmask neurology drug targets

Ono Pharma will use Aitia's causal AI digital twins to find new drug targets in neurological disease.

By

Superluminal scores $60M to carry AI-designed obesity pill to clinic

Superluminal Medicines banks $60M to take its AI-designed MC4R obesity drug into Phase 1.

By

Seattle’s big three institutes launch $95M AI BioDesign accelerator

Allen Institute, UW and Fred Hutch launch the $95M AI BioDesign accelerator to engineer biology with AI.

By

Europe approves Vara’s AI to clear normal mammograms on its own

Vara's AI can now report clearly normal mammograms alone after a landmark CE certification.

By

Hospital-built AI screens myeloma trial candidates in seconds

Seoul St. Mary's Hospital built in-house AI that screens myeloma patients for trial eligibility in seconds.

By

Veeva’s Falcon Safety agents take over drug side-effect reporting

Veeva's Falcon Safety agents automate adverse event intake, case processing and follow-up across E2B safety systems.

By